HOUSTON, April 10, 2017 -- LINN Energy, Inc. (OTCQB:LNGG) announced today that its common stock has been approved for trading on the OTCQB market under the symbol LNGG. Investors can find real-time quotes and market information for the Company on www.otcmarkets.com. The Company believes the OTCQB (which is operated by the OTC Markets Group, Inc.) constitutes an “established securities market” within the meaning of the Foreign Investment in Real Property Tax Act of 1980 (“FIRPTA”).
ABOUT LINN ENERGY
LINN Energy, Inc. was formed in February 2017 as the reorganized successor to Linn Energy, LLC. Headquartered in Houston, Texas, the Company’s core focus area is the SCOOP / STACK / Merge in the Mid-Continent. Additional information about LINN Energy is available at www.linnenergy.com.
CONTACTS: LINN Energy, Inc. Investors: Thomas Belsha, Vice President — Investor Relations Brandon Powell, Analyst — Investor Relations (281) 840-4110 [email protected]


U.S. Sanctions Target Chinese Refinery Over Iranian Oil Purchases
U.S. Warns Allies Over Alleged Chinese AI IP Theft Linked to DeepSeek
DeepSeek Slashes AI Model Pricing to Boost Adoption and Challenge Global Rivals
Amazon Stock Rises as Meta Expands AWS Partnership for AI Infrastructure
European Car Sales Surge in March as EV and Hybrid Demand Accelerates
Judge Dismisses Elon Musk’s Fraud Claims Against OpenAI, Trial to Proceed on Remaining Allegations
Brazil Pension Fund Crackdown After Banco Master Collapse Raises Investment Concerns
U.S. Raises Alarm Over Chinese AI Firms’ Alleged IP Theft Through Model Distillation
Chinese Chip Stocks Surge on AI Boom and Domestic Tech Push
Strait of Hormuz Shipping Crisis Deepens as Traffic Plunges Amid Iran-U.S. Tensions
Kia Cuts EV Prices in Europe as Chinese Carmakers Intensify Competition
Daiichi Sankyo Stock Drops After Earnings Delay and Oncology Review
Hyundai Plans 20 New Models in China to Boost EV Strategy and Market Share
U.S. Demand for Alternative Satellite Providers Remains Strong Amid SpaceX Regulatory Push
Sun Pharma to Acquire Organon in $11.75 Billion Deal to Boost Global Women’s Health Portfolio 



